Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

The survival prospects for children and adolescents with cancer in China have improved markedly, with the overall five-year ...

Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.

Immunome, Inc. (NASDAQ: IMNM) is one of the stocks Jim Cramer offered insights on. When a caller inquired about the stock, ...

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...

Lung cancer incidence rates in the United States have undergone a significant transformation over the last several decades, ...

The five-year survival rate for all cancers combined in the US reached a landmark 70% for Americans diagnosed between 2015 ...

An annual report from the American Cancer Society shows that, for the first time, over 70% of Americans diagnosed with cancer ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

While the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal cancers ...

The American Cancer Society (ACS) today released Cancer Statistics, 2026, the organization's annual report on cancer facts and trends. The new findings show, for the first time, the five-year relative ...